VAPS Mode of Ventilation
Volume-Assured Pressure Support (VAPS), also known as Volume-Targeted BiPAP (VT-BPAP), is a noninvasive ventilation mode that automatically adjusts inspiratory pressure within preset limits (IPAPmin to IPAPmax) to deliver a targeted tidal volume, providing consistent ventilatory support despite changes in respiratory mechanics or patient effort. 1
How VAPS Works
VAPS operates as a hybrid mode combining the benefits of pressure and volume ventilation:
- Automatic pressure adjustment: The ventilator continuously modulates IPAP between minimum and maximum limits to achieve the target tidal volume 1, 2
- Adaptive support: If respiratory muscle strength declines and tidal volume drops, the device automatically increases pressure support to restore the targeted volume 1
- Available modes: Can be used in spontaneous, spontaneous-timed (ST), or timed modes 1
The key advantage is maintaining consistent minute ventilation through day-night variations and disease progression without requiring manual pressure adjustments 2, 3.
Initial Settings (Based on AASM Guidelines)
When initiating VAPS, use these specific parameters 1:
- EPAP: 4 cm H₂O (higher if concurrent obstructive sleep apnea)
- IPAPmin: EPAP + 4 cm H₂O (typically 8 cm H₂O)
- IPAPmax: 25-30 cm H₂O
- Target tidal volume: 8 mL/kg ideal body weight
- Backup rate (if using ST mode): Equal to or slightly below spontaneous sleeping respiratory rate (minimum 10 bpm)
- Inspiratory time: 30-40% of cycle time 1
Clinical Indications
VAPS is indicated for chronic alveolar hypoventilation syndromes, particularly when 1, 4:
Primary Indications:
- Neuromuscular diseases (Duchenne muscular dystrophy, spinal muscular atrophy, ALS) where respiratory muscle strength fluctuates 5, 6
- Restrictive chest wall diseases requiring consistent ventilatory support 7
- Obesity hypoventilation syndrome 5
- Congenital central hypoventilation syndrome 5, 8
- Chronic hypercapnic respiratory failure when conventional BiPAP fails to maintain adequate ventilation 2, 8
Specific Clinical Scenarios:
- Patients with progressive neuromuscular weakness where manual pressure adjustments would be frequently needed 1
- When conventional BiPAP at maximum tolerated pressures fails to correct hypoventilation 8
- Pediatric patients with nocturnal hypoventilation uncontrolled by standard BiPAP 8
Evidence for Effectiveness
Current evidence shows VAPS is as effective as conventional BiPAP for gas exchange and sleep quality, with potential advantages in specific populations 2:
- Equivalence to BiPAP: Meta-analyses show no significant difference in gas exchange, sleep quality, or quality of life between VAPS and standard BiPAP 2
- Improved adherence: In pediatric neuromuscular disease, VAPS demonstrated better adherence (8.4 vs 7.2 hours daily usage, p=0.012) compared to ST mode 6
- Better CO₂ control: VAPS showed significant improvement in peak and mean transcutaneous CO₂ compared to conventional BiPAP in pediatric hypoventilation (p=0.009 and p=0.001 respectively) 8
- Reduced exacerbations: Emerging evidence suggests VAPS may reduce exacerbation frequency in COPD patients 2
Titration Goals
The primary goals when using VAPS are 1:
- Select effective EPAP to eliminate obstructive events
- Document adequate pressure support delivery by the device
- Achieve normocapnia (PaCO₂ ≤ awake value or reduce by ≥20%)
- Maintain SpO₂ >90%
- Ensure adequate tidal volume (6-8 mL/kg)
- Provide respiratory muscle rest
Common Pitfalls and Troubleshooting
Critical Caveats:
Leak management is crucial 1: High mask or mouth leak degrades flow signal accuracy, making tidal volume estimates unreliable. If increasing pressure support fails to raise tidal volume, suspect excessive leak and address mask fit before further pressure adjustments.
EPAP adjustment for comorbid OSA 1, 7: When obstructive sleep apnea coexists, EPAP must be titrated higher than the standard 4 cm H₂O to eliminate obstructive events—ideally guided by sleep study.
Backup rate necessity 1: VAPS in spontaneous mode provides no breaths if the patient fails to trigger. Always use ST mode with backup rate in:
- Central hypoventilation syndromes
- Significant central apneas
- Unreliable triggering due to muscle weakness
- Inappropriately low respiratory rate
Device-specific algorithms 9: VAPS algorithms are proprietary and differ between manufacturers. When transitioning between devices, settings cannot be directly transferred—retitration is necessary.
Practical Implementation
Follow this approach for VAPS initiation:
- Start with standard settings (EPAP 4, IPAPmin 8, IPAPmax 25-30, target VT 8 mL/kg)
- Titrate EPAP first if obstructive events present
- Monitor delivered tidal volume and adjust target if needed
- Add backup rate if central events, low respiratory rate, or weak triggering
- Reassess at 1 month with arterial blood gas, then every 3-6 months 7
The theoretical advantage of VAPS—automatic adjustment to changing respiratory mechanics—has not yet been proven to improve long-term outcomes like survival 2. However, it represents an acceptable and potentially superior option for patients requiring consistent ventilatory support despite fluctuating respiratory muscle strength or disease progression.